{"id":291,"date":"2019-02-22T09:02:54","date_gmt":"2019-02-22T17:02:54","guid":{"rendered":"https:\/\/derm-biomepharmaceuticals.com\/?p=291"},"modified":"2019-03-20T09:05:11","modified_gmt":"2019-03-20T16:05:11","slug":"derm-biome-pharmaceuticals-inc-announces-an-exciting-collaboration-with-harvard-medical-school","status":"publish","type":"post","link":"https:\/\/derm-biomepharmaceuticals.com\/de_de_formal\/derm-biome-pharmaceuticals-inc-announces-an-exciting-collaboration-with-harvard-medical-school\/","title":{"rendered":"Derm-Biome Pharmaceuticals Inc. gibt eine spannende Zusammenarbeit mit der Harvard Medical School bekannt"},"content":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text]<\/p>\n
VANCOUVER, British Columbia \u2013 Derm-Biome Pharmaceuticals Inc, ein biopharmazeutisches Start-up-Unternehmen mit Sitz in Vancouver, freut sich, die Zusammenarbeit mit Dr. Anna Mandinova und der Abteilung f\u00fcr Dermatologie der Harvard Medical School bekannt zu geben. \u201eIch habe mich an Poul (Dr. Sorensen) gewandt, als ich von seinem neuen Vorhaben erfuhr. Durchbr\u00fcche in der klinischen Dermatologie sind im Vergleich zu anderen medizinischen Bereichen recht selten, daher klingt der Leitwirkstoff von Derm-Biome sehr faszinierend. Ich freue mich wirklich darauf, es an unseren von Patienten stammenden Hautmodellen zu testen, die die Biologie gutartiger und b\u00f6sartiger epidermaler Tumore sowie die hom\u00f6ostatische epidermale Regeneration und die Funktion von Hautstammzellen genau nachbilden.\u201c sagte Dr. Mandinova.<\/p>\n
F\u00fcr Zusammenarbeit und Investorenanfragen: geberwein(at)Derm-biome.com<\/strong> [\/vc_column_text][vc_empty_space][vc_empty_space][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner width=”1\/2″][vc_single_image image=”184″ img_size=”medium” alignment=”center” qode_css_animation=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image image=”115″ img_size=”medium” alignment=”center” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][vc_separator type=”normal” color=”#cccccc” thickness=”1″ up=”50″ down=”50″][\/vc_column][\/vc_row]<\/p>","protected":false},"excerpt":{"rendered":" [vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] February 22, 2019 VANCOUVER, British Columbia \u2014 Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, is excited to announce that it will be collaborating with Dr. Anna Mandinova and the Department of Dermatology at Harvard Medical School. \u201cI reached out to Poul (Dr. Sorensen) when I […]<\/p>","protected":false},"author":2,"featured_media":282,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recent-news"],"yoast_head":"\n
\nwww.derm-biomepharmaceuticals.com<\/strong><\/p>\n